Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis.
Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Hough G, Wagner A, Nakamura K, Garber DW, Datta G, Segrest JP, Hama S, Fogelman AM. Navab M, et al. Among authors: van lenten bj. Curr Opin Investig Drugs. 2003 Sep;4(9):1100-4. Curr Opin Investig Drugs. 2003. PMID: 14582455 Review.
Oxidized lipids as mediators of coronary heart disease.
Navab M, Hama SY, Reddy ST, Ng CJ, Van Lenten BJ, Laks H, Fogelman AM. Navab M, et al. Among authors: van lenten bj. Curr Opin Lipidol. 2002 Aug;13(4):363-72. doi: 10.1097/00041433-200208000-00003. Curr Opin Lipidol. 2002. PMID: 12151851 Review.
The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.
Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fonarow GC, Vahabzadeh K, Hama S, Hough G, Kamranpour N, Berliner JA, Lusis AJ, Fogelman AM. Navab M, et al. Among authors: van lenten bj. J Lipid Res. 2004 Jun;45(6):993-1007. doi: 10.1194/jlr.R400001-JLR200. Epub 2004 Apr 1. J Lipid Res. 2004. PMID: 15060092 Free article. Review.
An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice.
Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Wagner AC, Hama S, Hough G, Bachini E, Garber DW, Mishra VK, Palgunachari MN, Fogelman AM. Navab M, et al. Among authors: van lenten bj. Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1932-7. doi: 10.1161/01.ATV.0000174589.70190.e2. Epub 2005 Jun 16. Arterioscler Thromb Vasc Biol. 2005. PMID: 15961700
The double jeopardy of HDL.
Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Hama S, Hough G, Bachini E, Grijalva VR, Wagner AC, Shaposhnik Z, Fogelman AM. Navab M, et al. Among authors: van lenten bj. Ann Med. 2005;37(3):173-8. doi: 10.1080/07853890510007322. Ann Med. 2005. PMID: 16019715 Review.
Potential clinical utility of high-density lipoprotein-mimetic peptides.
Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Datta G, Garber D, Fogelman AM. Navab M, et al. Among authors: van lenten bj. Curr Opin Lipidol. 2006 Aug;17(4):440-4. doi: 10.1097/01.mol.0000236371.27508.d4. Curr Opin Lipidol. 2006. PMID: 16832169 Review.
Mechanisms of disease: proatherogenic HDL--an evolving field.
Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fogelman AM. Navab M, et al. Among authors: van lenten bj. Nat Clin Pract Endocrinol Metab. 2006 Sep;2(9):504-11. doi: 10.1038/ncpendmet0245. Nat Clin Pract Endocrinol Metab. 2006. PMID: 16957764 Review.
63 results